Comparison of expression pattern of monoamine oxidase A with histopathologic subtypes and tumour grade of renal cell carcinoma

Medical Science Monitor

Volumn 18, Issue 12, 2012, Pages

  Hodorová, Ingrid ^a   Rybárová, Silvia ^a   Vecanová, Janka ^a   Solár, Peter ^a   Domoráková, Iveta ^a   Adamkov, Marián ^b   Mihalik, Jozef ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

Immunohistochemical expression; Monoamine oxidase; Renal cell carcinoma

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;

ADULT; ARTICLE; CANCER GRADING; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; KIDNEY DISTAL TUBULE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AGED; CARCINOMA, RENAL CELL; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; NEOPLASM GRADING;

EID: 84874764679     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883592     Document Type: Article

References (18)

1. Uramoto H, Sugio K, Oyama T et al: Expression of the p53 family in lung cancer. Anticancer Res, 2006, 26(3A): 1785-90
2. Gabrilovich DI: INGN 201 (Advexin): adenoviral p53 gene therapy for cancer. Expert Opin Biol Ther, 2006; 6(8): 823-32
3. Pietrangeli P, Mondovì B: Amine oxidases and tumors. Neurotoxicology, 2004; 25(1-2): 317-24
4. Shih JC, Chen K, Ridd MJ: Monoamine oxidase: from genes to behavior. Annu Rev Neurosci, 1999, 22: 197-217
5. Youdim MB, Edmondson D, Tipton KF: The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci, 2006; 7(4): 295-309
6. Rodriguez MJ, Saura J, Billet EE et al: Cellular localization of monoamine oxidase A and B in human tissues outsider of the central nervous systém. Cell Tissue Res, 2001, 304: 215-20
7. True L, Coleman I, Hawley S et al: A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci USA, 2006; 103(29): 10991-96
8. Stamey TA, McNeal JE, Yemoto CM et al: Biological determinants of cancer progression in men with prostate cancer. JAMA, 1999; 281(15): 1395-400
9. Humphrey PA: Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol, 2004; 17(3): 292-306
10. Tilan J, Kitlinska J: Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression. J Oncol, 2010; 2010: 539706
11. Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics, 2010. CA Cancer J Clin, 2010; 60(5): 277-300
12. Ferlay J, Shin HR, Bray F et al: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10 [Internet]. International Agency for Research on Cancer, 2010
13. Maslinski C, Bieganski T, Fogel WA, Kitler MA: Diamine oxidase in developin tissues. In: Mondovi B (ed.), Sturucture and functions of amine oxidases. Boca Raton, FL, CRC Press, 1985; 153-66
14. Ha HC, Woster PM, Casero RA Jr: Polyamines aspoison and protectors. In: Bardocz S, Koninkx J, Grillo M, White A (eds.), Biologically active amines in food processing and amines produced by bacteria, and poluamines and tumor growth, vol. 3; 1999; 114
15. Sarabia SF, Liehr JG: Induction of monoamine oxidase B by 17 beta-estradiol in the hamster kidney preceding carcinogenesis. Arch Biochem Biophys, 1998; 355(2): 249-53
16. Peehl DM, Coram M, Khine H et al: The significance of monoamine oxidase-A expression in high grade prostate cancer. J Urol, 2008; 180(5): 2206-11
17. Chiou SH, Ku HH, Tsai TH et al: Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway. Br J Pharmacol, 2006; 148(5): 587-98
18. Zhao H, Flamand V, Peehl DM: Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics, 2009; 2: 55